Medicare Enrolled

Dr. Thadeus Dapash, D.O

Gastroenterology · Charlotte, NC
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
300 BILLINGSLEY RD STE 200, Charlotte, NC 28211
7043727974
Registered in NPPES since 2015
NPI: 1871976902 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Dapash from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Dapash? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Dapash

Dr. Thadeus Dapash is a gastroenterology specialist in Charlotte, NC, with 11 years of NPI registration. Based on federal Medicare data, Dr. Dapash performed 666 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Dapash received a total of $13,985 from 51 pharmaceutical and/or device companies across 650 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Dapash is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 11 years of NPI registration ▲ Top 41% volume in NC $13,985 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
666
Medicare services
Top 41% in NC for gastroenterology
Not available
Unique patients (not deduplicated)
$97
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Upper GI endoscopy with biopsy
A procedure to collect tissue samples from the esophagus, stomach, or upper small intestine using a flexible tube with a camera. The samples are examined to check for abnormalities.
116 $69 $583
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
91 $67 $176
Colon polyp removal with endoscopic snare
This procedure removes polyps or growths from the large bowel using a flexible tube with a camera and a wire loop tool. The snare is used to cut off the growths during the examination.
72 $198 $1,045
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
56 $100 $326
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
44 $87 $260
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
43 $50 $172
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
42 $71 $263
Colonoscopy with biopsy
A procedure to collect tissue samples from the large intestine using a flexible tube with a camera. The samples are examined to check for abnormalities or disease.
39 $125 $882
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
38 $91 $400
Dilation of esophagus 36 $29 $306
Colonoscopy for colorectal cancer screening, high risk
A colonoscopy performed to screen for colorectal cancer in individuals identified as being at high risk for the disease.
31 $177 $735
Colonoscopy
A diagnostic exam of the large bowel using a flexible endoscope to visualize the interior of the colon.
29 $123 $735
Upper endoscopy (EGD)
A diagnostic exam of the esophagus, stomach, and upper small bowel using a flexible endoscope.
16 $68 $495
Colonoscopy for colorectal cancer screening
A colonoscopy performed to screen for colorectal cancer in individuals who are not at high risk for the disease.
13 $170 $735
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.

Industry Payment Transparency

Open Payments through 2024 ↗
$13,985
Total received (2018-2024)
Avg $1,998/year across 7 years
Top 13% in NC for gastroenterology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
51
Companies
650
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$4,082
2023
$2,162
2022
$1,671
2021
$2,986
2020
$1,741
2019
$794
2018
$549

Payments by company (2024)

ABBVIE INC.
$1,067
Janssen Biotech, Inc.
$558
Phathom Pharmaceuticals, Inc.
$264
GENZYME CORPORATION
$223
Takeda Pharmaceuticals U.S.A., Inc.
$218
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$189
VIVUS LLC
$189
Janssen Scientific Affairs, LLC
$149
3-D Matrix, Inc.
$144
AIMMUNE THERAPEUTICS, INC.
$124
Medtronic, Inc.
$110
Regeneron Healthcare Solutions, Inc.
$109
Celgene Corporation
$86
Ipsen Biopharmaceuticals, Inc
$84
Lilly USA, LLC
$72
Gilead Sciences, Inc.
$63
Merck Sharp & Dohme LLC
$59
Organon Llc
$56
Madrigal Pharmaceuticals
$45
QOL Medical, LLC
$40
Celltrion USA Inc.
$38
IRONWOOD PHARMACEUTICALS, INC
$37
Ardelyx, Inc.
$30
Alcresta Therapeutics, Inc.
$28
Ultragenyx Pharmaceutical Inc.
$19
Fresenius Kabi USA, LLC
$18
Sandoz Inc.
$17
PFIZER INC.
$17
Intercept Pharmaceuticals, Inc.
$16
Eisai Inc.
$13
Top 3 companies account for 46.3% of 2024 payments
All-time payments by company (2018-2024) ›
AbbVie Inc.
$2,101
ABBVIE INC.
$2,086
Janssen Biotech, Inc.
$1,178
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$1,073
Takeda Pharmaceuticals U.S.A., Inc.
$831
GENZYME CORPORATION
$437
PFIZER INC.
$398
Daiichi Sankyo Inc.
$348
AbbVie, Inc.
$346
Axonics, Inc.
$294
Janssen Scientific Affairs, LLC
$274
Phathom Pharmaceuticals, Inc.
$264
Amarin Pharma Inc.
$241
Ardelyx, Inc.
$234
VIVUS LLC
$216
Amgen Inc.
$213
Boehringer Ingelheim Pharmaceuticals, Inc.
$198
RedHill Biopharma Inc.
$197
Novo Nordisk Inc
$193
Ferring Pharmaceuticals Inc.
$189
Celgene Corporation
$174
Regeneron Healthcare Solutions, Inc.
$171
Gilead Sciences, Inc.
$165
3-D Matrix, Inc.
$144
Intercept Pharmaceuticals, Inc.
$142
QOL Medical, LLC
$131
Braintree Laboratories, Inc.
$127
E.R. Squibb & Sons, L.L.C.
$125
AIMMUNE THERAPEUTICS, INC.
$124
Allergan Inc.
$118
Merck Sharp & Dohme LLC
$116
Ironwood Pharmaceuticals, Inc
$112
AstraZeneca Pharmaceuticals LP
$112
Medtronic, Inc.
$110
Lilly USA, LLC
$101
Nestle HealthCare Nutrition Inc.
$100
NESTLE HEALTHCARE NUTRITION INC.
$87
IRONWOOD PHARMACEUTICALS, INC
$86
Ipsen Biopharmaceuticals, Inc
$84
Organon Llc
$56
Madrigal Pharmaceuticals
$45
Exact Sciences Corporation
$41
Celltrion USA Inc.
$38
Sandoz Inc.
$37
Alcresta Therapeutics, Inc.
$28
EISAI INC.
$20
Ultragenyx Pharmaceutical Inc.
$19
Fresenius Kabi USA, LLC
$18
INTERCEPT PHARMACEUTICALS, INC.
$18
Novartis Pharmaceuticals Corporation
$14
Eisai Inc.
$13
Top 3 companies account for 38.4% of all-time payments
Associated products mentioned in payments ›
AVSOLA · Axonics · BYDUREON · Bylvay · CIMZIA · CREON · CYRAMZA · Cologuard Collection Kit · Creon · DIFICID · DUPIXENT · Dojolvi · ENTRESTO · ENTYVIO · Enbrel · Epclusa · FORTEO · GATTEX · GI GENIUS · HADLIMA · HUMIRA · HYRIMOZ · Humira · IBSRELA · IDACIO · INJECTAFER · INTERSTIM · IQIRVO · JARDIANCE · LINZESS · Lenvima · Linzess · MAVYRET · MOTOFEN · MOVANTIK · Mavyret · Motegrity · Movantik · Norditropin · OCALIVA · OMVOH · ONTRUZANT · PANCREAZE · Qsymia · REBYOTA · RELISTOR · RELIZORB · REMICADE · RESMETIROM · RINVOQ · SKYRIZI · STELARA · SUCRAID · SUFLAVE · SUTAB · Saxenda · Sucraid · TREMFYA · TRULANCE · Talicia · VEGZELMA · VIBERZI · VOQUEZNA · Vascepa · XELJANZ · XIFAXAN · ZENPEP · ZEPOSIA
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a gastroenterology specialist in Charlotte?
Compare gastroenterologists in the Charlotte area by procedure volume, costs, and industry payment transparency.
Browse gastroenterologists nearby

Geographic Context

Gastroenterologists in nearby ZIP areas
85
County median income
$83,765
Nearest hospital to ZIP centroid (approximate)
ATRIUM HEALTH PINEVILLE
4.2 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Dapash is a clinical cardiology specialist, with moderate Medicare volume.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Dapash experienced with upper gi endoscopy with biopsy?
Based on Medicare claims data, Dr. Dapash performed 116 upper gi endoscopy with biopsy services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Dapash receive payments from pharmaceutical companies?
Yes. Dr. Dapash received a total of $13,985 from 51 companies across 650 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Dapash's costs compare to other gastroenterologists in Charlotte?
Dr. Dapash's average Medicare payment per service is $97. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Dapash) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →